Entrada Therapeutics, Inc. (TRDA)
13.99
+0.43
(+3.17%)
USD |
NASDAQ |
Apr 17, 16:00
14.27
+0.28
(+2.00%)
Pre-Market: 20:00
Entrada Therapeutics Free Cash Flow : -129.55M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Tyra Biosciences, Inc. | -95.28M |
| Biogen, Inc. | 1.969B |
| EyePoint, Inc. | -243.39M |
| Vertex Pharmaceuticals, Inc. | 3.194B |
| Arcutis Biotherapeutics, Inc. | -16.31M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -32.20M |
| Cash from Investing (Quarterly) | 29.12M |
| Cash from Financing (Quarterly) | 0.192M |
| Free Cash Flow Per Share (Quarterly) | -0.7691 |
| Free Cash Flow to Equity (Quarterly) | -30.53M |
| Free Cash Flow to Firm (Quarterly) | -32.00M |
| Free Cash Flow Yield | -22.38% |